The FDA has released draft guidance for NAMs Validation – Now what?
On March 18th, the FDA published draft guidance on validating new approach methodologies (NAMs), including complex in vitro models (CIVMs).
9 Apr 05:35 · News-Medical
last updated on 9 Apr 07:37